FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 20252,844-16.90%
Mar 31, 20243,423+54.94%
Mar 31, 20232,209-15.03%
Mar 31, 20222,600-35.75%
Mar 31, 20214,047-32.45%
Mar 31, 20205,990+26.18%
Mar 31, 20194,747+14.56%
Mar 31, 20184,144+12.09%
Mar 31, 20173,697+5.49%
Mar 31, 20163,505+142.07%
Mar 31, 20151,448
AI Chat